Jin Seon Jeong

Dr. Jin Seon Jeong

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
HJHae Hyuk Jung
Hae Hyuk Jung
JPJi In Park
Ji In Park
JJJin Seon Jeong
Jin Seon Jeong
Incidence of diabetes and its mortality according to body mass index in South Koreans aged 40-79 years Hae Hyuk Jung, Ji In Park, Jin Seon Jeong Department of Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Gangwon-do, South Korea Purpose: The purpose of this study was to assess diabetes incidence and all-cause mortality according to baseline body mass index (BMI) and to compare relative risks of mortality associated with incident diabetes across various BMI classes in a cohort of South Korean adults.Patients and methods: Based on data from the National Health Insurance database of Korean individuals aged 40â

10 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
JKJi Eun Kim
Ji Eun Kim
DHDohyun Han
Dohyun Han
KKKyu Hong Kim
Kyu Hong Kim
ASAreum Seo
Areum Seo
JMJong Joo Moon
Jong Joo Moon
SYSeung Hee Yang
Seung Hee Yang
Peritoneal dialysis is a common treatment for end‐stage renal disease, but complications often force its discontinuation. Preventive treatments for peritoneal inflammation and fibrosis are currently lacking. Cyclo(His‐Pro) (CHP), a naturally occurring cyclic dipeptide, has demonstrated protective effects in various fibrotic diseases, yet its potential role in peritoneal fibrosis (PF) remains uncertain. In a mouse model of induced PF, CHP was administered, and quantitative proteomic analysis using liquid chromatography–tandem mass spectrometry was employed to identify PF‐related protein signaling pathways. The results were further validated using human primary cultured mesothelial cells. This analysis revealed the involvement of histone deacetylase 3 (HDAC3) in the PF signaling pathway. CHP administration effectively mitigated PF in both peritoneal tissue and human primary cultured mesothelial cells, concurrently regulating fibrosis‐related markers and HDAC3 expression. Moreover, CHP enhanced the expression of nuclear factor erythroid 2‐related factor 2 (Nrf2) while suppressing forkhead box protein M1 (FOXM1), known to inhibit Nrf2 transcription through its interaction with HDAC3. CHP also displayed an impact on spleen myeloid‐derived suppressor cells, suggesting an immunomodulatory effect. Notably, CHP improved mitochondrial function in peritoneal tissue, resulting in increased mitochondrial membrane potential and adenosine triphosphate production. This study suggests that CHP can significantly prevent PF in peritoneal dialysis patients by modulating HDAC3 expression and associated signaling pathways, reducing fibrosis and inflammation markers, and improving mitochondrial function.

3 January 2022 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
HPHanui Park
Hanui Park
MLMiji Lee
Miji Lee
JJJin Seon Jeong
Jin Seon Jeong
Background: Immunoglobulin A vasculitis (IgA vasculitis) is one of the most common forms of vasculitis in children. It rarely occurs in adults. It is a systemic vasculitis with IgA deposition and is characterized by the classical tetrad of purpura, arthritis/arthralgia, gastrointestinal and renal involvement. Certain types of infections, and pharmacological agents have been reported to be associated with IgA vasculitis. Here, we describe a case of IgA vasculitis triggered by infective endocarditis in a patient undergoing maintenance hemodialysis. Case presentation: A 70-year-old man undergoing hemodialysis was admitted because of skin purpura, abdominal pain, diarrhea, and lower back pain. We suspected him as IgA vasculitis based on the clinical features and skin biopsy findings. Transesophageal echocardiography revealed infective endocarditis, which predisposed him to IgA vasculitis. He was treated with antibiotics and low-dose corticosteroids, which led to resolution of vasculitis. Conclusions: This is the first case of IgA vasculitis triggered by infective endocarditis in a patient undergoing hemodialysis. Patients undergoing hemodialysis are at a high risk of infection because of immune dysfunction and frequent venipuncture. The incidence of infective endocarditis associated with IgA vasculitis is very low, but it has been repeatedly reported. Therefore, it is necessary to consider infective endocarditis in patients with clinical features that indicate IgA vasculitis.

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JJJin Seon Jeong
Jin Seon Jeong
YLYoung Lee
Young Lee
SLSunhwa Lee
Sunhwa Lee
HBHyunjeong Baek
Hyunjeong Baek
MCMyung-Jin Choi
Myung-Jin Choi
JPJi In Park
Ji In Park
Jeong JS, et al. J Korean Med Sci. 2024 Aug;39:e280. https://doi.org/10.3346/jkms.2024.39.e280

15 July 2024 in The FASEB Journal
Verified
Journal Article
Closed access
JKJi Eun Kim
Ji Eun Kim
DHDohyun Han
Dohyun Han
KKKyu Hong Kim
Kyu Hong Kim
ASAreum Seo
Areum Seo
JMJong Joo Moon
Jong Joo Moon
SYSeung Hee Yang
Seung Hee Yang